Paula Lorgelly, University of Auckland, Waipapa Taumata Rau
The government says funding for COVID vaccines and antivirals are up for consideration next year. With so much unknown about the long-term impact of COVID, will cost become a barrier to access?
Paula Lorgelly, University of Auckland, Waipapa Taumata Rau
Most parties are promising more funding for the government drug-buying agency. But two likely coalition partners are suggesting a new – and possibly risky – approach to medicines procurement.